Application for quotation of securities - PER

Oct 13, 2026 at 6:20 PM EDT · Issued by Percheron Therapeutics Limited via ASX

Filed with ASX · Oct 13, 2026 at 6:20 PM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-per-1

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 6Announcement SummaryEntity namePERCHERON THERAPEUTICS LIMITEDAnnouncement TypeNew announcementDate of this announcementWednesday October 14, 2026The +securities to be quoted are:Please...

View Attachment

6ix hasn’t read this filing yet.

Percheron Therapeutics Limited on 6ix

Earlier from Percheron Therapeutics

Change of Director's Interest NoticeOct 7
Notification regarding unquoted securities - PEROct 7
Results of Annual General MeetingOct 7
Annual General Meeting - Management PresentationOct 6
Annual General Meeting - Chair AddressOct 6

Later from Percheron Therapeutics

Notice under S708AOct 14
PER: Percheron and Invion Explore Cancer Combination TherapyOct 19
Photosoft & Novel Immunotherapy Collab PartnershipOct 19
Quarterly Activities Report and Appendix 4COct 19
Completion of HMBD-002 Drug Product ManufactureOct 22

All Percheron Therapeutics news releases

Follow Percheron Therapeutics into a list and get an email when it puts out news.

Follow Percheron Therapeutics